Medication Adherence Improvement Support App For Engagement - Blood Pressure
MedISAFE-BP
1 other identifier
interventional
413
1 country
1
Brief Summary
The purpose of this study is to evaluate the impact of the Medisafe smartphone application on blood pressure control and self-reported medication adherence for patients with uncontrolled blood pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Apr 2016
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2016
CompletedStudy Start
First participant enrolled
April 1, 2016
CompletedFirst Posted
Study publicly available on registry
April 4, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedJanuary 18, 2017
January 1, 2017
9 months
March 31, 2016
January 17, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in systolic blood pressure
Three months after randomization
Self-reported medication adherence
Three months after randomization
Secondary Outcomes (1)
Change in number of subjects who have well controlled blood pressure
Three months after randomization
Study Arms (2)
Control
NO INTERVENTIONParticipants randomized to this arm will not receive the intervention.
Intervention
EXPERIMENTALParticipants randomized to this arm will receive the intervention, Medisafe, a smartphone application.
Interventions
Medisafe is a smartphone application available to download for free on any iOS or Android device. Medisafe addresses non-adherence by providing alerts to patients when it is time to take their medications. Other features include the ability to allow a "Medfriend" to check in if a medication is not taken, weekly reports of medication adherence, and monitoring of biometric measurements
Eligibility Criteria
You may qualify if:
- Between 18 - 75 years of age
- Self-reported systolic blood pressure greater than or equal to 140 mmHg
- Self-reported use of 1-3 of the following anti-hypertensive medications (thiazide, CCB, beta-blocker, ACE-I, ARB)
- Systolic blood pressure greater than or equal to140 mmHg (+/- diastolic blood pressure greater than or equal to 90 mmHg), but blood pressure less than or equal to 180/120 mmHg confirmed by home BP-cuff
You may not qualify if:
- Current use of a smartphone medication adherence application
- No ownership of a smartphone with iOS or Android operating system
- Currently taking more than 3 anti-hypertensive medications (thiazide, CCB, beta-blocker, ACE-I, ARB) by self report
- Currently undergoing dialysis
- Currently receiving chemotherapy or radiation
- Does not understand English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brigham and Women's Hospitallead
- Medisafe, Inc.collaborator
- Evidation Healthcollaborator
Study Sites (1)
Evidation Health
Menlo Park, California, 94025, United States
Related Publications (1)
Morawski K, Ghazinouri R, Krumme A, Lauffenburger JC, Lu Z, Durfee E, Oley L, Lee J, Mohta N, Haff N, Juusola JL, Choudhry NK. Association of a Smartphone Application With Medication Adherence and Blood Pressure Control: The MedISAFE-BP Randomized Clinical Trial. JAMA Intern Med. 2018 Jun 1;178(6):802-809. doi: 10.1001/jamainternmed.2018.0447.
PMID: 29710289DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Niteesh K Choudhry, MD, PhD
Center for Healthcare Delivery Sciences, Brigham and Women's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Harvard Medical School and Executive Director, Center for Healthcare Delivery Sciences, Department of Medicine, Brigham and Women's Hospital
Study Record Dates
First Submitted
March 31, 2016
First Posted
April 4, 2016
Study Start
April 1, 2016
Primary Completion
January 1, 2017
Study Completion
January 1, 2017
Last Updated
January 18, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share